September 9, 2020
InSysBio announces the new version of Cytocon DB 1.2.6.7! Cytocon DB team has reviewed 39 articles to implement the new data. It should be highlighted that the total number of reviewed articles within the Database has already exceeded 515!
The DB was extended with new data, namely:
The table shows the actual number of components available in Cytocon DB 1.2.6.7.
To get more information about the latest version of Cytocon DB, please, visit its website.
About InSysBio
InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.
| ← | June 2026 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
|
8
|
9
|
10
1.
10 Jun 2026 17:00
16th InSysBio’s Annual Internal Scientific Meeting
InSysBio held its 16th Annual Internal Scientific Meeting. The Meeting combined a warm and welcoming atmosphere with insightful discussions on key priorities and future opportunities, strengthening the team's strong engagement and collaborative spirit.
|
11
|
12
|
13
|
14
|
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
|
22
|
23
|
24
1.
24 Jun 2026 16:51
InSysBio to take part in JuliaCon 2026
InSysBio announces its participation in JuliaCon Global 2026 which is to be held from August 10-15, 2026 at Johannes Gutenberg University Mainz, Germany. Ivan Borisov and Evgeny Metelkin will give a talk "VPopMIP: A Mixed-Integer Programming Approach to Virtual Population Generation"
|
25
|
26
|
27
|
28
|
|
29
|
30
| |||||
Thank you for your message! We will get back to you shortly.
